×

Do you want to link to this External Site and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this Amgen Site outside the UK and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Please note, this page is intended for UK healthcare professionals. By clicking to enter this page you are confirming that you are a UK healthcare professional.

×

Do you want to link to this Amgen Site and leave Amgen.co.uk?

Please note this site is only intended for UK Healthcare professionals and UK patients that have been prescribed Prolia®

YOU ARE NOW LEAVING THIS WEBSITE.

Products

At Amgen, our mission is to serve patients. As a science-based, patient-focused organisation, we discover and develop innovative therapies to treat serious illnesses.Our medicines have made a dramatic difference in the lives of millions.

Amgen is committed to patient safety and continually monitors the safety and quality of our products. If you want to contact Amgen for any of the following reasons, please call us on +44 (0)1223 436441 (UK and Ireland), Freephone: 1800 535160 (Ireland) and provide us with the details:

  • You think you may have experienced an adverse event ('side effect') after taking or using an Amgen product.
  • You think there may be a defect or quality issue with the Amgen product you have received.
  • You have a general medical information enquiry about your Amgen product.

If you are in the UK, you may also report adverse events or product defects directly to the Medicines and Healthcare products Regulatory Agency (MHRA)  where you can also find reporting forms and information.

If you are in Ireland, you may also report adverse events or product defects to the Health Products Regulatory Authority (HPRA) where you can also find reporting forms and information.

To read more about the Falsified Medicines Directive and the impact this may have on Amgen packaging, click here.


Below you will find information on Amgen’s product portfolio. Prescribing information and patient information leaflets for each product can be downloaded through the links. These links direct you to the Electronic Medicines Compendium (eMC) and Medicines.ie websites; and provide information about all medicines available in the UK and Ireland respectively.

Please note that this information is specific to the UK and Ireland.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Total of 12 Products

Amgen is committed to patient safety and continually monitors the safety and quality of our products. Adverse events and product quality issues should be reported.

▼ This product is subject to additional monitoring.

For the UK - reporting forms and information can be found at http://yellowcard.mhra.gov.uk/

For Ireland - reporting forms and information can be found at http://www.hpra.ie/

Adverse events and product quality issues should also be reported to Amgen. To report a potential adverse event or quality issue with an Amgen product, or for medical information enquiries, please call +44 (0) 1223 436441 (UK and Ireland) Freephone: 1800 535160 (Ireland).

Job Code: UKIE-CC-NPS-0918-067857

Date of preparation: January 2019